Across 6 review studies, all reported beneficial effects of Bifidobacterium plantarum (or probiotic multispecies containing it) on gut microbiota balance, with 5 showing moderate effect sizes and 1 showing small. However, none of the studies provided statistical significance or original clinical data, limiting the strength of this conclusion.
Caveats: All 6 studies are reviews with no original clinical trial data; the specific role of Bifidobacterium plantarum alone is only explicitly mentioned in one study. Population heterogeneity (CKD, obesity, livestock) and absence of dose information further reduce confidence. No studies reported statistical significance.
promotes gut microbial balance
Clinical studies have demonstrated that the combination of prebiotics, probiotics, and synbiotics-supplements that aid in the establishment of intestinal microbiota-can effectively help control the production of nitrogenous substances, reduce renal inflammation, and alleviate gastrointestinal symptoms in patients with CKD.
probiotics, through their ability to restore gut micro-ecology, strengthen the intestinal barrier integrity, modulate the immune system, and mitigate systemic inflammation, offer a promising add-on therapy to traditional CKD therapies
probiotics are a safe and promising therapeutic approach for managing metabolic disorders. Several in vivo and clinical studies have reported a potential causal relationship between probiotic supplementation and the improvement of weight-related conditions... highlighting the potential role of probiotics in restoring microbiota balance and improving metabolic dysfunctions related to excess body weight.
Bifidobacterium plantarum ... were observed to regulate gut microflora balance and enhance host digestive health.
Probiotics, such as Lactobacillus, Bifidobacterium, and Saccharomyces, modulate the gut microbiota, enhance the gut barrier, and regulate the immune system.
LPQ supplementation restored microbial balance, increasing short-chain fatty acid-producing genera (Lactobacillus, Bifidobacterium, Blautia, and Faecalibaculum) and reducing potentially pathogenic taxa.